Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Research Domains
  1. Home
  3. Research Domains

Related Concept Videos

  • Biomedical And Clinical Sciences
  • Oncology And Carcinogenesis
  • Predictive And Prognostic Markers
  • Type Of Cftr Mutation Determines Risk Of Pancreatitis In Patients With Cystic Fibrosis.
  • Biomedical And Clinical Sciences
  • Oncology And Carcinogenesis
  • Predictive And Prognostic Markers
  • Type Of Cftr Mutation Determines Risk Of Pancreatitis In Patients With Cystic Fibrosis.

    • Related Experiment Videos

    Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis.

    Chee Y Ooi1, Ruslan Dorfman, Marco Cipolli

    • 1Physiology and Experimental Medicine, The Research Institute, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.

    Gastroenterology
    |October 7, 2010

    View abstract on PubMed

    Summary
    This summary is machine-generated.

    Cystic fibrosis gene (CFTR) mutations influence pancreatitis risk. Mild CFTR genotypes increase pancreatitis risk compared to moderate-severe ones, impacting disease management.

    Related Experiment Videos

    Area of Science:

    • Genetics
    • Gastroenterology
    • Pulmonology

    Background:

    • Cystic fibrosis (CF) gene (CFTR) mutations impact exocrine pancreas function differently.
    • The relationship between CFTR genotype and pancreatitis risk in CF patients is not fully understood.

    Purpose of the Study:

    • To investigate if specific CFTR genotypes determine the risk of developing pancreatitis in patients with cystic fibrosis.

    Main Methods:

    • Analysis of CFTR genotypes and clinical data from 277 pancreatic-sufficient CF patients (62 with pancreatitis, 215 without).
    • Utilized the pancreatic insufficiency prevalence (PIP) score to categorize CFTR genotype-associated pancreatic function loss.

    Main Results:

    • Patients with pancreatitis were more likely to have mild (70%) versus moderate-severe (30%) PIP scores (P = .004).
    • The cumulative risk of pancreatitis by age 50 was higher for mild (50%) vs. moderate-severe (27%) PIP score genotypes (P = .006).
    • Mild PIP score genotypes showed a 2.4-fold increased hazard ratio for pancreatitis (P = .006).

    Conclusions:

    • Specific CFTR genotypes are significantly associated with pancreatitis risk in CF patients.
    • Genotypes linked to milder CFTR phenotypes confer a higher risk of pancreatitis.
    • Findings offer insights into the complex pathogenesis of pancreatitis in CF.